Tayo Adebiyi
Nessuna posizione attualmente
Profilo
Tayo Adebiyi has been Senior Director of Quality for MonoSol Rx, Inc. since April, 2007.
Previously, he was Director of the Quality Operations of the Drug Product Division for Pfizer.
Mr. Adebiyi worked with Enzon Pharmaceuticals, Inc. (formerly Enzon, Inc.) from 1998 to 2001.
He led analytical R&D as well as quality operations at The Liposome Co., Inc. Mr. Adebiyi has over 25 years of diverse scientific and quality experience in the pharmaceutical industry.
Precedenti posizioni note di Tayo Adebiyi
| Società | Posizione | Fine |
|---|---|---|
The Liposome Co., Inc.
 The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
| ENZON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| AQUESTIVE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Health Technology |
- Borsa valori
- Insiders
- Tayo Adebiyi
